Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Neurosci ; 28(26): 6569-82, 2008 Jun 25.
Article in English | MEDLINE | ID: mdl-18579730

ABSTRACT

The mistrafficking and consequent cytoplasmic accumulation of cholesterol and sphingolipids is linked to multiple neurodegenerative diseases. One class of disease, the sphingolipid storage diseases, includes Niemann-Pick disease type C (NPC), caused predominantly (95%) by mutation of the NPC1 gene. A disease model has been established through mutation of Drosophila NPC1a (dnpc1a). Null mutants display early lethality attributable to loss of cholesterol-dependent ecdysone steroid hormone production. Null mutants rescued to adults by restoring ecdysone production mimic human NPC patients with progressive motor defects and reduced life spans. Analysis of dnpc1a null brains shows elevated overall cholesterol levels and progressive accumulation of filipin-positive cholesterol aggregates within brain and retina, as well as isolated cultured brain neurons. Ultrastructural imaging of dnpc1a mutant brains reveals age-progressive accumulation of striking multilamellar and multivesicular organelles, preceding the onset of neurodegeneration. Consistently, electroretinogram recordings show age-progressive loss of phototransduction and photoreceptor synaptic transmission. Early lethality, movement impairments, neuronal cholesterol deposits, accumulation of multilamellar bodies, and age-dependent neurodegeneration are all rescued by targeted neuronal expression of a wild-type dnpc1a transgene. Interestingly, targeted expression of dnpc1a in glia also provides limited rescue of adult lethality. Generation of dnpc1a null mutant neuron clones in the brain reveals cell-autonomous requirements for dNPC1a in cholesterol and membrane trafficking. These data demonstrate a requirement for dNPC1a in the maintenance of neuronal function and viability and show that loss of dNPC1a in neurons mimics the human neurodegenerative condition.


Subject(s)
Aging/metabolism , Brain/metabolism , Cholesterol/metabolism , Drosophila Proteins/genetics , Membrane Proteins/genetics , Nerve Degeneration/metabolism , Neurons/metabolism , Aging/genetics , Animals , Biological Transport, Active/genetics , Brain/pathology , Brain/physiopathology , Cell Survival/genetics , Cells, Cultured , Disease Models, Animal , Drosophila melanogaster , Filipin/metabolism , Gene Expression Regulation, Developmental/genetics , Genes, Lethal/genetics , Inclusion Bodies/genetics , Inclusion Bodies/metabolism , Inclusion Bodies/pathology , Intracellular Membranes/metabolism , Mice , Mutation/genetics , Nerve Degeneration/genetics , Nerve Degeneration/physiopathology , Neurons/pathology , Niemann-Pick C1 Protein , Niemann-Pick Diseases/genetics , Niemann-Pick Diseases/metabolism , Niemann-Pick Diseases/physiopathology , Organelles/genetics , Organelles/metabolism , Organelles/pathology , Photoreceptor Cells, Invertebrate/metabolism , Photoreceptor Cells, Invertebrate/pathology , Retinal Diseases/genetics , Retinal Diseases/metabolism , Retinal Diseases/physiopathology
2.
IEEE Trans Biomed Eng ; 44(8): 694-705, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9254983

ABSTRACT

Developing a clinically useful closed-loop drug delivery system can be extremely time consuming and costly. One approach to reducing the time and cost associated with developing closed-loop systems is to reduce the number of animal experiments and perform an extensive set of simulation studies. Through simulations, a closed-loop controller's performance can be evaluated over a complete spectrum of the patient population, including boundary conditions. Simulation studies are repeatable, offering significant advantages in comparing modifications in control algorithms. Finally, simulation studies can be performed in a fraction of the time required for animal studies, at a fraction of the cost. We have developed a simulator, that included a nonlinear pulsatile-flow cardiovascular model, a physiological regulatory mechanism, and the pharmacology of four frequently titrated cardiovascular drugs. This simulator has already been used in the design and evaluation of two closed-loop algorithms-a self-tuning regulator (STR) and a multiple model adaptive controller (MMAC)-for blood pressure control during and after cardiac surgery.


Subject(s)
Algorithms , Cardiovascular Agents/administration & dosage , Drug Delivery Systems , Models, Cardiovascular , Cardiovascular Agents/pharmacokinetics , Dobutamine/administration & dosage , Dobutamine/pharmacokinetics , Dopamine/administration & dosage , Dopamine/pharmacokinetics , Equipment Design , Nitroglycerin/administration & dosage , Nitroglycerin/pharmacokinetics , Nitroprusside/administration & dosage , Nitroprusside/pharmacokinetics , Nonlinear Dynamics , Pulsatile Flow
SELECTION OF CITATIONS
SEARCH DETAIL
...